Antonio M. Jimenez Jimenez

Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant

M. Perales, S. Devlin, L. Lekakis, 2022, Blood advances.

Access: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

B. Shaw, S. Spellman, S. Choi, 2022, Blood.

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

F. Baron, M. Krem, C. Hourigan, 2021, Bone Marrow Transplantation.

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.

S. Zeger, G. Gui, C. Hourigan, 2023, JAMA.